Pipeline Database
UB273
Ampicillin Sodium and Sulbactam Sodium for Injection
UB273
ProductAmpicillin Sodium and Sulbactam Sodium for Injection
Strength0.5g: 0.25g; 1.0g: 0.5g
IndicationsRespiratory tract infection; Hepatobiliary infection; Urinary tract infection; Skin and soft tissue infection; Intra-abdominal infection; Pelvic infection; Polymicrobial infection
TherapeuticsInfectious Diseases
GMPCN - NMPA
RegistrationChina
ModalitiesSmall Molecule
Exclusive Summary
- • No IP barriers: Original Unasyn patents expired long ago; open, fully genericized markets globally.
- • Broad hospital use-cases: Effective for bite wounds, mixed aerobic–anaerobic infections, obstetric/gynecologic infections, diabetic foot/SSTI, and aspiration-related pneumonia.
- • Guideline-aligned: Recommended by multiple national/international guidelines and widely stocked as an essential hospital injectable antibiotic.
- • Supply reliability wins: Periodic global shortages in beta-lactam/BL-BLI classes create entry points for quality-assured, on-time suppliers.
- • Cost-competitive: Typically 80–95% below originator; tenders in LMICs often <US$1 per 1.5 g vial; OECD hospitals ~US$2–6/vial.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →